Skip to main content
EJNMMI Reports
Fig. 6 | European Journal of Hybrid Imaging

Fig. 6

From: 18F-fluorothymidine (FLT)-PET and diffusion-weighted MRI for early response evaluation in patients with small cell lung cancer: a pilot study

Fig. 6

FDG-SUVpeak, FLT-SUVpeak, and ADCmedian in lesions with response vs. lesions with no change or progression. T-sites are shown in left panel (a–c) and N-sites in right panel (d–f). Note that no T-sites progressed during chemotherapy, and no N-sites had no change. FLT-SUVpeak was significantly different in T-sites with response vs. no change (b) and in N-sites with response vs. progression (e). Three lesions with response had no signal on DW-MRI and are not included (c). Lesions that were not evaluated for response are included for completeness. NA*: response evaluation was not available due to atelectasis. NA**: The patient died prior to any response evaluation

Back to article page